Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2005
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy
03/17/2005US20050058728 Administering rosehips, resveratrol, astaxanthin, blackberry, blueberry, and/or elderberry to inhibit interleukin synthesis; antiinflammatory agents; cardiovascular disorders, pain, stiffness
03/17/2005US20050058667 Adjuvants for use in vaccines
03/17/2005US20050058657 Vaccines for treatment of Aids
03/17/2005US20050058648 Antibodies against caspase-8, their preparation and use
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005US20050058626 Vaccine against pathogens
03/17/2005DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives
03/17/2005CA2536775A1 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
03/17/2005CA2535895A1 Anti-cd20 therapy of ocular disorders
03/16/2005EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514551A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
03/16/2005EP1514549A1 Powdery respiratory tonic composition
03/16/2005EP1514544A1 Antiallergic
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders
03/16/2005EP1513553A1 Methods and materials for treating inflammatory conditions
03/16/2005EP1513552A1 Packaged virus-like particles for use as adjuvants: method of preparation and use
03/16/2005EP1513543A2 Fas peptide mimetics and uses thereof
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
03/16/2005EP1513524A2 Ether substituted imidazopyridines
03/16/2005EP1513522A2 Methods of treating conditions associated with an edg receptor
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES
03/16/2005EP1513509A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1453510A4 Neurotransmitter balance chemotherapy
03/16/2005EP1351962B1 Thienopyrimidine
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596124A Delivery system for biological component
03/16/2005CN1596118A Therapeutical treatments
03/16/2005CN1596116A Anticancer compositions
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1594587A Preparation for fungus extracellular polysaccharide compound and application thereof
03/16/2005CN1594360A Red cashew nut legumin and its preparation and use
03/16/2005CN1594346A Flavanone glycoside and its preparation and use
03/16/2005CN1594345A 3-hydroxy-chromogen ketoside and its preparation and use
03/16/2005CN1594319A Process for extracting ginkgolide, ginkgolide injection and process for preparing same
03/16/2005CN1593578A Immunity regulating medicine
03/16/2005CN1593567A Compound Chinese herbal medicinal for intensifying immunity
03/16/2005CN1593543A Method for preparing compound Chinese medicinal tonifying liquor
03/16/2005CN1593469A Novel pharmaceutical use of effective part group of sappan wood
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193016C Process for synthesizing inhibitor of phosphatidase A2
03/16/2005CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/16/2005CN1192799C Adjuvant combination formulations
03/16/2005CN1192798C Vaccine
03/16/2005CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV)
03/16/2005CN1192788C Medicine for resisting allergic reaction and its preparation method
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867207 IL-5 inhibiting 6-azauracil derivatives
03/15/2005US6866846 Extracting body fluid containing immune complexes relevant to immunopathological condition; complexing with adsorbent; elution; fractionating, immobilization onto biocompatible carriers activated to bond to its surface
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2149826C 7-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
03/15/2005CA2124964C Cdw52-specific antibody for treatment of multiple sclerosis
03/15/2005CA2121678C Vitamin d amide derivatives
03/10/2005WO2005021546A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021503A1 Aminopropanol derivatives
03/10/2005WO2005021019A1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences
03/10/2005WO2005021003A2 Immunosuppressive effects of pteridine derivatives
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 1172